During the past decade, National Hospital Organization Kanazawa Medical Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 11 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Kanazawa Medical Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Bayer" with 5 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kanazawa Medical Center" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kanazawa Medical Center" are "Ulcerative Colitis" (4 trials), "Heart Failure" (2 trials), "Low Back Pain" (2 trials), "Major Depressive Disorder" (2 trials) and "Respiratory Syncytial Virus Infections" (2 trials). Many other conditions were trialed in "National Hospital Organization Kanazawa Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Kanazawa Medical Center" are "Drug" (21 trials), "Biological" (4 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Etrasimod" (3 trials), "Finerenone (BAY94-8862)" (2 trials), "Tanezumab 5 mg" (2 trials) and "ALS-008176" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Kanazawa Medical Center" are 24 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Kanazawa Medical Center". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in National Hospital Organization Kanazawa Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Kanazawa Medical Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".